KITLG and diabetic kidney disease: Yin et al. have found that MCs infiltration promotes interstitial fibrosis in diabetic nephropathy through the SCF/c-kit pathway and that inhibition of the SCF/c-kit pathway may alleviate interstitial fibrosis [21].